Star Sports Medicine Co., Ltd. will convene its 2026 annual shareholders’ meeting at 10:00 a.m. on 26 June 2026 in Beijing. Shareholders will vote on 13 resolutions, split into nine ordinary and four special items.

Key ordinary resolutions: • Review of the 2025 board and supervisory board work reports, final accounts, audited financial statements, and profit-distribution plan. • Approval of the 2026 financial budget. • Re-appointment of Ernst & Young Hua Ming LLP as financial auditor for 2026. • Confirmation of remuneration packages for executive directors, non-executive directors, independent non-executive directors, and senior management for 2026.

Special resolutions of strategic significance: • Abolition of the company’s Supervisory Board. • Amendments to the Articles of Association and the procedural rules for shareholders’ and board meetings. • Granting a general mandate to repurchase up to 10% of issued H-shares during the mandate period, subject to Hong Kong Listing Rules. • Granting a general mandate to issue new shares; specific quantitative limits were not disclosed in the notice.

Shareholders registered by 26 June 2026 are eligible to vote. The H-share register will be closed from 23 June 2026 to 26 June 2026. Proxy forms must be lodged with Computershare Hong Kong Investor Services by 10:00 a.m. on 25 June 2026.